Alasdair G. Kay
Mesenchymal stem cell-conditioned medium reduces disease severity and immune responses in inflammatory arthritis
Kay, Alasdair G.; Long, Grace; Tyler, George; Stefan, Andrei; Broadfoot, Stephen J.; Piccinini, Anna M.; Middleton, Jim; Kehoe, Oksana
Authors
Grace Long
George Tyler
Andrei Stefan
Stephen J. Broadfoot
ANNA PICCININI ANNA.PICCININI@NOTTINGHAM.AC.UK
Assistant Professor
Jim Middleton
Oksana Kehoe
Abstract
We evaluated the therapeutic potential of mesenchymal stem cell-conditioned medium (CM-MSC) as an alternative to cell therapy in an antigen-induced model of arthritis (AIA). Disease severity and cartilage loss were evaluated by histopathological analysis of arthritic knee joints and immunostaining of aggrecan neoepitopes. Cell proliferation was assessed for activated and naïve CD4+ T cells from healthy mice following culture with CM-MSC or co-culture with MSCs. T cell polarization was analysed in CD4+ T cells isolated from spleens and lymph nodes of arthritic mice treated with CM-MSC or MSCs. CM-MSC treatment significantly reduced knee-joint swelling, histopathological signs of AIA, cartilage loss and suppressed TNFα induction. Proliferation of CD4+ cells from spleens of healthy mice was not affected by CM-MSC but reduced when cells were co-cultured with MSCs. In the presence of CM-MSC or MSCs, increases in IL-10 concentration were observed in culture medium. Finally, CD4+ T cells from arthritic mice treated with CM-MSC showed increases in FOXP3 and IL-4 expression and positively affected the Treg:Th17 balance in the tissue. CM-MSC treatment reduces cartilage damage and suppresses immune responses by reducing aggrecan cleavage, enhancing Treg function and adjusting the Treg:Th17 ratio. CM-MSC may provide an effective cell-free therapy for inflammatory arthritis.
Citation
Kay, A. G., Long, G., Tyler, G., Stefan, A., Broadfoot, S. J., Piccinini, A. M., …Kehoe, O. (2017). Mesenchymal stem cell-conditioned medium reduces disease severity and immune responses in inflammatory arthritis. Scientific Reports, 7, Article 18019. https://doi.org/10.1038/s41598-017-18144-w
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 5, 2017 |
Online Publication Date | Dec 21, 2017 |
Publication Date | Dec 21, 2017 |
Deposit Date | Jan 10, 2018 |
Publicly Available Date | Jan 10, 2018 |
Journal | Scientific Reports |
Electronic ISSN | 2045-2322 |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 7 |
Article Number | 18019 |
DOI | https://doi.org/10.1038/s41598-017-18144-w |
Public URL | https://nottingham-repository.worktribe.com/output/901538 |
Publisher URL | https://www.nature.com/articles/s41598-017-18144-w |
Contract Date | Jan 10, 2018 |
Files
41598_2017_18144_MOESM1_ESM.pdf
(316 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
s41598-017-18144-w.pdf
(2.2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
miR-155-3p: processing by-product or rising star in immunity and cancer?
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search